摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-bis(4-(tetradecyloxy)phenyl)-1H-pyrazole | 457081-60-6

中文名称
——
中文别名
——
英文名称
3,5-bis(4-(tetradecyloxy)phenyl)-1H-pyrazole
英文别名
3,5-bis(4-tetradecoxyphenyl)-1H-pyrazole
3,5-bis(4-(tetradecyloxy)phenyl)-1H-pyrazole化学式
CAS
457081-60-6
化学式
C43H68N2O2
mdl
——
分子量
645.025
InChiKey
LWPXQDSEEZXVSS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    743.1±60.0 °C(Predicted)
  • 密度:
    0.964±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    16.8
  • 重原子数:
    47
  • 可旋转键数:
    30
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.65
  • 拓扑面积:
    47.1
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:209928890886696a0924d12d1a42606c
查看

反应信息

  • 作为反应物:
    描述:
    di(rhodium)tetracarbonyl dichloride 、 3,5-bis(4-(tetradecyloxy)phenyl)-1H-pyrazole 在 KOH 作用下, 以 甲醇 为溶剂, 以55%的产率得到(Rh(CO)2C3HNN(C6H4OC14H29)2)2
    参考文献:
    名称:
    基于介晶3,5-二取代吡唑配体的Rh(I)配合物的化学。3,5-二叔的X射线晶体结构(4- Ñ -butoxyphenyl)吡唑(HPZ BP2)和铑[Rh(μ-PZ R2)(CO)2 ] 2(R = C 6 H ^ 4 OC ñ ħ 2 Ñ +1,n = 10,12)个化合物。第二部分
    摘要:
    四个新的3,5-二取代的吡唑Hpz R2,它们含有长链的4- n-烷氧基苯基取代基[R = C 6 H 4 OC n H 2 n +1 ; n = 4(1),6(2),12(5),14(6)]已经制备并表征。它们均表现出同构行为,中间相的稳定性和范围随吡唑上链的长度而增加。Hpz bp2(1)的X射线结构显示出高度线性的分子形状。推导了剩余的Hpz R2的相关结果并且结构上的结果与观察到的介晶性质一致。介晶基吡唑HPZ R2(1 - 6)被用作向[的RhCl(CO)配体2 ]和[铑(CO)2 ]片段。[的RhCl(CO)2(HPZ R2)]配合物(7 - 12)显示出依赖于长链的吡唑类,以及与在固体状态下不同的分子阵列一些物理性质。在所有情况下,这些化合物进化到的[Rh(μ-PZ R2)(CO)2 ] 2的溶液中。的吡唑特的Rh(I)配合物的[Rh(μ-PZ R2)(CO)2 ]2(13 –
    DOI:
    10.1016/s0022-328x(02)01400-6
  • 作为产物:
    描述:
    十四烷基碘化物 在 sodium hydride 、 potassium carbonate一水合肼 作用下, 以 乙二醇二甲醚乙醇丙酮 为溶剂, 反应 8.0h, 生成 3,5-bis(4-(tetradecyloxy)phenyl)-1H-pyrazole
    参考文献:
    名称:
    基于介晶3,5-二取代吡唑配体的Rh(I)配合物的化学。3,5-二叔的X射线晶体结构(4- Ñ -butoxyphenyl)吡唑(HPZ BP2)和铑[Rh(μ-PZ R2)(CO)2 ] 2(R = C 6 H ^ 4 OC ñ ħ 2 Ñ +1,n = 10,12)个化合物。第二部分
    摘要:
    四个新的3,5-二取代的吡唑Hpz R2,它们含有长链的4- n-烷氧基苯基取代基[R = C 6 H 4 OC n H 2 n +1 ; n = 4(1),6(2),12(5),14(6)]已经制备并表征。它们均表现出同构行为,中间相的稳定性和范围随吡唑上链的长度而增加。Hpz bp2(1)的X射线结构显示出高度线性的分子形状。推导了剩余的Hpz R2的相关结果并且结构上的结果与观察到的介晶性质一致。介晶基吡唑HPZ R2(1 - 6)被用作向[的RhCl(CO)配体2 ]和[铑(CO)2 ]片段。[的RhCl(CO)2(HPZ R2)]配合物(7 - 12)显示出依赖于长链的吡唑类,以及与在固体状态下不同的分子阵列一些物理性质。在所有情况下,这些化合物进化到的[Rh(μ-PZ R2)(CO)2 ] 2的溶液中。的吡唑特的Rh(I)配合物的[Rh(μ-PZ R2)(CO)2 ]2(13 –
    DOI:
    10.1016/s0022-328x(02)01400-6
点击查看最新优质反应信息

文献信息

  • Diphosphines and pyrazole/pyrazolate-type ligands as building blocks in luminescent Au(I) complexes
    作者:María José Mayoral、Paloma Ovejero、Rosario Criado、M. Cristina Lagunas、Aranzazu Pintado-Alba、M. Rosario Torres、Mercedes Cano
    DOI:10.1016/j.jorganchem.2011.04.022
    日期:2011.8
    (I)-diphosphine derivatives with a bridging pyrazolate ligand are obtained in all cases, except when [Au2Cl2(μ-biphep)] is used as starting material. Surprisingly, in this case, two monodentate neutral pyrazole ligands are attached to the gold atoms. The new complexes are luminescent in the solid state at 77 K and in solution both at room temperature and 77 K. Low energy emission bands related to the presence
    合成了一系列含有二苯基膦桥联配体dppm,dppe,dpephos,dbfphos和biphep的金(I)配合物以及吡唑类型的共配体。的X射线晶体结构[金2(μ-dpephos)(μ-PZ 2CH3)] [PF 6 ],[金2(μ-dbfphos)(μ-PZ 2CH3)] [PF 6 ]和的起始化合物[Au 2 Cl 2(μ-biphep)]表明新络合物的结构和化学计量特性取决于二膦配体。这三种络合物显示出Au⋯Au接触在3.27Å和3.30Å之间,而二苯丙啶化合物的Au⋯Au接触最短。在所有情况下均获得具有桥连的吡唑酸酯配体的Digold(I)-二膦衍生物,不同之处在于,将[Au 2 Cl 2(μ-biphep)]用作原料。令人惊讶地,在这种情况下,两个单齿中性吡唑配体连接到金原子上。新的配合物在固态时在77 K下发光,并且在室温和77 K下在溶液中发光。在某些固态和/或化合物中已发现与
  • Silver and gold luminescent metallomesogens based on pyrazole ligands
    作者:María José Mayoral、Paloma Ovejero、José Antonio Campo、José Vicente Heras、Elena Pinilla、María Rosario Torres、Carlos Lodeiro、Mercedes Cano
    DOI:10.1039/b808487d
    日期:——
    A series of ionic bis(pyrazole)-silver(I) and -gold(I) complexes [ML2][A] (M = Ag, Au; A = BF4−, PF6−, NO3−), prepared by coordination of the mesomorphic L = Hpz2R(n) or non-mesomorphic L = HpzR(n) pyrazole ligands (Hpz2R(n) = 3,5-bis(4-alkyloxyphenyl)pyrazole; HpzR(n) = 3-(4-alkyloxyphenyl)pyrazole), has been studied. The complexes exhibit enantiotropic behaviour, showing smectic A (SmA) mesophases. The choice of the ligands allows the achievement of ‘H’ or ‘U’ molecular shapes, which appear to be responsible for the attainment of liquid crystal mesophases, these not being dependent on the coordinating or non-coordinating nature of the A counteranions. The new complexes are photoluminescent both in the solid state and in solution at room temperature. In addition, the luminescent behaviour of selected compounds as a function of the temperature indicates that the luminescence is maintained in the mesophase.
    一系列离子型双(吡唑)-银(I)和-金(I)配合物[ML2][A](M = Ag, Au;A = BF4-、PF6-、NO3-)配位制备的中形态 L = Hpz2R(n) 或非中形态 L = HpzR(n) 吡唑配体(Hpz2R(n) = 3,5-双(4-烷氧基苯基)吡唑;HpzR(n) = 3-(4-烷氧基苯基)吡唑)。这些配合物表现出各向异性,呈现出 Smectic A (SmA) 介相。配体的选择可以实现 "H "或 "U "分子形状,这似乎是实现液晶介相的原因,而这些并不取决于 A 反阳离子的配位或非配位性质。在室温下,这些新复合物在固态和溶液中都能发光。此外,所选化合物的发光行为与温度的函数关系表明,发光在介相中得以保持。
  • Bridged 3,5-disubstituted pyrazolate ligands as support of metallomesogens containing [Pd(η3-C3H5)]+ fragments
    作者:M.C Torralba、M Cano、S Gómez、J.A Campo、J.V Heras、J Perles、C Ruiz-Valero
    DOI:10.1016/s0022-328x(03)00669-7
    日期:2003.10
    The mesomorphic properties of two new long-chain 3,5-(4-n-alkoxyphenyl)pyrazoles Hpz(R2) (R = C6H4OCnH2n+1, n = 16, 18) have been studied and compared with those of related compounds containing shorter chains (n = 4, 6, 8, 10, 12, 14). For liquid crystal purposes, the derivative with 14 carbon atoms in the chain behaves as the best compound on the basis of the lowest melting point and the widest stability range of the mesophases. New Pd(II) complexes of formula [Pd(eta(3)-C3H5)(mu-pz(R2))](2) (R = C6H4OCnH2n+1, n = 8, 10, 12, 14, 16, 18) (1-6) containing the mesomorphic ligands as pyrazolate-bridging groups have been prepared and characterised. In solution, three conformational isomers (two symmetric and one asymmetric corresponding to different orientations of the allyl groups) have been found. In the solid state, the X-ray crystal structure of 3 (n = 12) evidenced the asymmetric isomer. The structure shows a bowlic core drawn on the basis of the boat-like conformation of the six-membered ring Pd(NN)(2)Pd. However, a rod-like shape could also be considered by taking the molecular dimensionality into account (47.80 Angstrom in length x 4.75 Angstrom in wide). The Pd-complexes 2-6 were found to have liquid crystal properties exhibiting enantiotropic smectic phases consistent with the molecular characteristics. Moreover, the molecular packing of 3 is described as the layer-like type in which the molecules are parallel to the c-axis but tilted off the layer, this fact appearing similar to the molecular ordering in the smectic fluid phases. (C) 2003 Elsevier B.V. All rights reserved.
  • Chemistry of Rh(I) complexes based on mesogenic 3,5-disubstituted pyrazole ligands. X-ray crystal structures of 3,5-di(4-n-butoxyphenyl)pyrazole (Hpzbp2) and [Rh(μ-pzR2)(CO)2]2 (R=C6H4OCnH2n+1, n=10, 12) compounds. Part II
    作者:M.C Torralba、M Cano、J.A Campo、J.V Heras、E Pinilla、M.R Torres
    DOI:10.1016/s0022-328x(02)01400-6
    日期:2002.7
    for the remained HpzR2 and the structural consequences agree with the observed mesomorphic properties. The mesogenic pyrazoles HpzR2 (1–6) were used as ligands towards [RhCl(CO)2] and [Rh(CO)2] fragments. [RhCl(CO)2(HpzR2)] complexes (7–12) showed some physical properties dependant on the long-chained pyrazoles, and related to different molecular arrays in the solid state. In all cases these compounds
    四个新的3,5-二取代的吡唑Hpz R2,它们含有长链的4- n-烷氧基苯基取代基[R = C 6 H 4 OC n H 2 n +1 ; n = 4(1),6(2),12(5),14(6)]已经制备并表征。它们均表现出同构行为,中间相的稳定性和范围随吡唑上链的长度而增加。Hpz bp2(1)的X射线结构显示出高度线性的分子形状。推导了剩余的Hpz R2的相关结果并且结构上的结果与观察到的介晶性质一致。介晶基吡唑HPZ R2(1 - 6)被用作向[的RhCl(CO)配体2 ]和[铑(CO)2 ]片段。[的RhCl(CO)2(HPZ R2)]配合物(7 - 12)显示出依赖于长链的吡唑类,以及与在固体状态下不同的分子阵列一些物理性质。在所有情况下,这些化合物进化到的[Rh(μ-PZ R2)(CO)2 ] 2的溶液中。的吡唑特的Rh(I)配合物的[Rh(μ-PZ R2)(CO)2 ]2(13 –
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺